EDAP TMS SA (EDAP)
3.23
-0.17
(-5.00%)
USD |
NASDAQ |
Dec 29, 16:00
3.26
+0.03
(+0.93%)
After-Hours: 20:00
EDAP TMS EPS Diluted (Quarterly): -0.1565 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -1.207 |
| Cellectis SA | 0.0058 |
| Genfit SA | -- |
| Ascendis Pharma A/S | -1.173 |
| Akari Therapeutics Plc | -0.1948 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.859M |
| Revenue (Quarterly) | 16.22M |
| Total Expenses (Quarterly) | 22.08M |
| Enterprise Value | 117.23M |
| Gross Profit Margin (Quarterly) | 43.02% |
| Profit Margin (Quarterly) | -36.13% |
| Earnings Yield | -17.98% |
| Normalized Earnings Yield | -17.98 |